We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Feastr is a UK-based multi-brand cloud kitchen business that delivers restaurant-quality food to a customer's doorstep in 30 minutes or less. The company asserts that operating from cloud kitchens within densely populated areas allows it to exploit the booming food delivery market without the huge overheads associated with bricks and mortar restaurants. Feastr operates its restaurants on aggregators such as Deliveroo, Uber Eats, and Just Eat, capitalising on their huge ready customer base. The company has had sales of over £550,000 since its launch in November 2019. It will use the investment to open three new locations, push its digital marketing campaign with new ideas in 2021, and prepare for its next round of fundraising.

Pitch Rated

49%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £346,487
Created is an academy for people who wish to enter the creative industries, one of the fastest growing sectors in the UK. It connects the gap between employment and education in the creative industries. It encourages education inside the UK’s £100bn+ creative industries by offering career accelerator courses. The academy proceeds with years of team expertise and experience in the creative industries and education. Created finished its first two rounds of funding amounting £610K from a blend of angels and corporate investors. Now, Created is seeking funds to develop further courses and support the recruitment of students.
days to go: Expired investment: £425,790
Cannabrew is one of the UK's first Cannabidiol (CBD) infused craft beers. It aspires to become a contender in the CBD market that is expected to reach £1 billion by 2025 in the UK. The company has sold thousands of cans across the UK despite COVID-19 and aims to become carbon-neutral soon. It assets that it plants two trees for every case of beer sold and has planted over 14,000 trees through a sustainability initiative in Madagascar by partnering with 'Ecologi', removing an estimated 350 tonnes of CO2 in just six months since the company's launch. Cannabrew was nominated for three awards at the World CBD Awards. Its product, Soul Lager, has become the highest-rated lager on Untappd in the UK achieving a score of >3.96. The company will use 25% of the investment in marketing, 50% towards team expansion, and 25% to scale production and boost New Product Development (NPD).
days to go: Expired investment: £216,695
Doisy & Dam (D&D) is a confectionery challenger brand that produces a range of dark chocolate products. It claims that its products are sold across the UK and stocked by Amazon, Sainsbury's, Holland & Barrett, Ocado, Boots, and other global markets. D&D's products are created using ethically sourced cocoa, natural ingredients and contain no traces of palm oil. The company aspires to become a contender in the UK confectionery market that was worth £3.9 billion in April 2021. It further points out that people are aware of the health and the sustainability credentials of the products they buy. It intends to target this sentiment and become an established brand. The company states it has grown its sales to over £1 million and aspires to become the best dark chocolate confectioner in the UK. D&D state they will use the investment for marketing, expanding its product range, and growing its export business.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £515,735
Auto Lease Compare is a company that uses a web-based platform to provide business services of leasing cars in the UK market. The company is on a mission to transform the growing UK car leasing industry. They are currently operating in a leasing & rental market worth £49 billion in the UK alone. Auto Lease Compare have increased their users to 40,000 on the platform and have also partnered with some of the UK’s leading leasing companies. With the investment, the company will grow its business by revamping and upgrading the website, executing a strong marketing strategy and increasing brand awareness.

Pitch Rated

76%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £111,860
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph